SUMMARY The inhibitory effects ofhydroxychloroquine on leucocyte motility have been compared with those ofprednisolone. It has been shown to have similar potency to prednisolone as an inhibitor of human neutrophil and monocyte motility. Hydroxychloroquine has then been compared with placebo in the prevention of an immune-complex experimental colitis in rabbits. Rectal biopsies were taken from rabbits 24 hours after initiation of colitis, coded, and graded histologically. The summated gradings for acute inflammation and goblet cell depletion had worsened more in the control rabbits (mean grade + 6.7) than in the treated rabbits (mean grade + 1.8) P<0.05. There was no difference in the mononuclear cell infiltrate between the two groups. Hydroxychloroquine, which is a potent inhibitor ofleucocyte motility, effectively prevents the acute inflammatory infiltrate in this experimental colitis model and therefore merits trial in human ulcerative colitis.
Prednisolone and other glucocorticoids are effective treatment for ulcerative colitis. 1 2 One of the known effects of prednisolone is the inhibition of leucocyte chemotaxis,34 and this may be important for its therapeutic action. The 4-amino quinoline, chloroquine, has also been shown to inhibit chemotaxis of leucocytes3 as has its derivative hydroxychloroquine,5 although the latter has not previously been tested using human leucocytes. Chloroquine has also been shown to prevent the accumulation of neutrophils into experimental Arthus lesions.3 There is, however, no record of chloroquine or hydroxychloroquine having been tried as therapy for human ulcerative colitis.
An experimental colitis model has previously been described in which a modified Auer reaction6
is induced in the colon of unsensitised rabbits by intravenous injection of immune complexes after dilute formaldehyde has been instilled rectally. It has been shown that the rectal instillation of formaldehyde causes the immune-complexes to be selectively deposited in the rectal mucosa where they initiate a chronic inflammatory response. The minutes and 75 minutes respectively, monocyte chemotaxis and random motility for two hours. They took place in a humidified incubator 'containing 5% CO2 at 37°C. Each filter was then fixed, stained, and mounted and the distance moved by the leading cell front was measured in five randomly selected high power fields using the micrometer focusing adjustment of a Leitz SM microscope. Each assay was run in triplicate so that each result represents the mean of 15 observations.
VIABILITY
Cell viability was measured after incubation for one hour in the test drug solution. It was tested by both trypan blue dye exclusion and by measurement of membrane chloride gradient. Membrane chloride gradient was measured using the method of Baur et al. 13 Three 0.5 ml aliquots of each cell suspension were taken. The first was incubated for 10 minutes at 37°C with 2.5 tCi 3H20/ml and the cells then separated from the supernatant by centrifugal filtration through silicon oil. Both the cell pellet and supernatant were then counted on a Phillips PW4530 scintillation counter after addition of 10 ml NE 260 scintillation cocktail (Nuclear Enterprises Limited). The intracellular water volume of the cell pellet was then calculated. The second aliquot was incubated for 10 minutes at 37°C with 0.5 sCi 14C inulin/ml and the cell pellet separated and counted as before. The adherent water was then calculated. The third aliquot was incubated for 10 minutes at 37°C with 0.5 gCi 36CVml at 37°C and the cell pellet again separated and counted. The intracellular chloride concentration was then calculated making allowance for the chloride content of the adherent water.
Results Colitis was induced in rabbits using the method of Hodgson et al.7 Twelve 2 kg male NZW rabbits were studied. Six were given 20 mg/kg hydroxychloroquine subcutaneously daily and six were given 0.4 ml physiological saline subcutaneously daily. A three day run-in period was allowed with the aim of achieving steady state drug levels and on the fourth day all 12 rabbits received 1 ml 1% formaldehyde rectally followed two hours later by 1 ml intravenously of human albumin (HSA)/ rabbit ant-HSA, complexes prepared in antigen excess.7 Rectal biopsies taken at 0, 24, and-120 hours were coded so that the histologist was unaware which rabbit they had come from and then graded from one to four for overall severity. Separate gradings were given for lamina propria, crypt and surface epithelial inflammatory infiltrates, and goblet cell depletion.
Venous blood samples were obtained from six of the rabbits (four treated and two saline controls) 20 hours after the last drug injection. These samples were assayed for hydroxychloroquine concentration using a Perkin-Elmer LC 1000 spectrofluorimeter with excitation wavelength 325 nm and emission wavelength 410 nm.
Results

CHEMOTAXIS FILTER ASSAY
Dose response curves were plotted for the percentage inhibition of leucocyte motility caused by serial dilutions of each test drug. By interpolation from these curves the drug concentrations required for 50% inhibition of neutrophil chemotaxis were prednisolone 1.45 gmol/l and hydroxychloroquine 0.23 gmol/l (Figs 1 and 2 ).
Similar drug concentrations produced inhibition of monocyte chemotaxis and inhibition of random motility of both neutrophils and monocytes (Table 1) . Table 2 shows the distance moved by the leading fronts of the control leucocyte populations used for these experiments (cells from the same leucocyte population incubated in the absence of drug).
These experiments were performed on leucocytes, from a single healthy subject. To exclude 100.
80. an idiosyncratic response of these leucocytes, drug concentrations similar to those required for 50% inhibition of random motility were then tested on leucocytes obtained from another four healthy subjects (two male and two female).
Prednisolone (2 gmol/l) caused 50% mean inhibition of neutrophil random motility (range 39-65%) and hydroxychloroquine (1 gmoVml) caused 36% mean inhibition of neutrophil random motility (range 31-41%).
To establish whether these drugs might simply be having a direct toxic effect neutrophils incubated for one hour in the same drug concentration were assessed for viability. Trypan blue dye exclusion was greater than 95% in each case. Cells incubated in the presence of prednisolone showed an increase in membrane chloride gradient of 14.4% and cells incubated in hydroxychloroquine showed an increase in membrane chloride gradient of only 8.6%.
Another experiment was performed to determine whether the inhibitory effects of the drugs studied were reversible. Aliquots of neutrophils were incubated for one hour at 37°C in the presence of prednisolone 2 tmoVml and hydroxychloroquine 1 gmoVml. Another aliquot was incubated in Gey's medium as control. After incubation half of each Five of the saline control rabbits showed evidence of colitis at 24 hours, while one was unchanged (mean worsening of overall grade + 1.5). One of the rabbits with features of severe colitis died at 72 hours. At 24 hours four of the six treated rabbits showed some evidence of colitis but this tended to be considerably milder (mean worsening ofoverall grade + 0.67), although the difference between control and treated rabbits did not reach significance using a Chi squared test for trend in proportions'4 (X2 = 1.75) ( Table 3) .
When the changes in gradings at 24 hours for acute inflammatory cell infiltrate, plasma cell infiltrate, and goblet cell depletion were summated, however, marked differences between the two Inhibition ofleucocyte motility and prevention by hydroxychloroquine Mean change in grade at 24 h = +0-67 *Died at 72 hours.
groups were revealed ( Table 4 ). The saline control rabbits showed considerably more acute inflammation and goblet cell depletion (mean grade + 6.5) than the hydroxychloroquine treated rabbits (mean grade + 1.8) and this difference was significant using the Wilcoxon rank sum test (P>0.05).
There was no significant difference in the lamina propria 'chronic' mononuclear cell infiltrate between the two groups (saline rabbits mean grade + 0.67, hydroxychloroquine treated rabbits mean grade + 0.83) and this is responsible for the relatively small difference in overall grades between the two groups. By 120 hours the colitis was resolving in all surviving rabbits contrary to the findings of Hodgson et aL 7 In the treated rabbits the hydroxychloroquine plasma levels 20 hours after the last injection ranged from 0.41 to 1.27 nmol/l (mean 0.71 nmol/ml. These are comparable with therapeutic plasma levels reported in man.'5 16 
Discussion
The results of the filter chamber assay demonstrate that hydroxychloroquine is at least as potent an inhibitor of leucocyte motility as prednisolone. Its The present study has shown that plasma levels of hydroxychloroquine comparable with therapeutic concentrations in man are sufficient to inhibit the acute inflammatory response in rabbits subjected to an immune-complex colitis. This was shown by the reduction in neutrophil and plasma cell infiltration and in goblet cell depletion in the rectal mucosa ofrabbits treated with hydroxychloroquine compared with the rabbits that received only saline. No effect of hydroxychloroquine was seen on the mononuclear infiltrate even though, in vitro, the drug affects monocyte and neutrophil motility to a similar degree. One possible explanation for this discrepancy is that macrophages and lymphocytes in the colonic mucosa may have a different response to drugs from peripheral blood monocytes. Although it seems likely that the inhibition of acute inflammatory cell accumulation seen here is due to a direct effect on cell motility, hydroxychloroquine and chloroquine affect several other leucocyte functions. They bind with DNA7 18 and modify its function. 19 
